eli lilly and company retatrutide delays weight loss drug filing to 2027 New GLP-1 obesity drug, retatrutide,

Microdosing may provide benefits without the gastrointestinal distress associated with traditional dosing

To break down what GLP-1s are, how they work, and who they might be right for, we sat down with Britleigh Garcia, PA-C, a clinician here at Nice Healthcare whos completed a certificate program in obesity management through the American Academy of Physician Assistants and The Obesity Society

Why GLP-1 Medications Increase Dehydration Risk GLP-1s raise dehydration risk for a few possible reasons

Within this framework, the present study critically examines the nutritional factors implicated in the pathogenesis of brain fog, with particular emphasis on inflammatory processes, gut-brain axis dysfunction, and sleep dysregulation

In patients who underwent both EGD and colonoscopy, the rate of retained gastric contents was 5.5%

The brand also references an "Advanced nano-delivery matrix" as the delivery technology, again without technical specification